13F filing recap · Q2 2007
What did Cantillon Capital Management buy in Q2 2007?
Reported stock-position changes between this filing and the previous one.
Stock value
$5.36B
Positions
93
Estimated turnover
31.7%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
CIThe Cigna Group$116.44Mreported value+2.23M sharesPEPPepsico, Inc.$81.18Mreported value+1.25M sharesCXCemex S.a.b. De C.v.$73.27Mreported value+1.99M sharesHOGHarley-Davidson, Inc.$46.75Mreported value+784.2K sharesEMCEmc Corp$38.97Mreported value+2.15M sharesQLGCQlogic Corporation$35.86Mreported value+2.15M sharesDJODJ Orthopedics Inc$11.97Mreported value+290.0K sharesAHOKoninklijke Ahold N.v.$10.61Mreported value+847.6K sharesSLHSolera Holdings Inc$7.79Mreported value+401.7K sharesSNYSanofi$6.47Mreported value+160.6K sharesETELEtelecare Global Solutions, Inc.$5.98Mreported value+369.9K sharesPHGKoninklijke Philips NV$5.39Mreported value+127.4K sharesGLWCorning Inc /ny$5.28Mreported value+206.7K sharesTCMTongjitang Chinese Medicines Co$5.06Mreported value+450.0K shares